» Articles » PMID: 38750545

Gynostemma Pentaphyllum Ameliorates CCl-induced Liver Injury Via PDK1/Bcl-2 Pathway with Comprehensive Analysis of Network Pharmacology and Transcriptomics

Overview
Journal Chin Med
Publisher Biomed Central
Date 2024 May 15
PMID 38750545
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Gynostemma pentaphyllum (Thunb.) Makino, commonly known as "southern ginseng", contains high amounts of ginsenoside derivatives and exhibits similar biological activities with Panax ginseng (C. A. MEY) (ginseng), which is usually used as a low-cost alternative to ginseng. G. pentaphyllum has therapeutic effects on liver diseases. However, the mechanisms underlying its hepatoprotective action have not been fully elucidated.

Methods: The protective effects of the ethanolic extract of G. pentaphyllum (GPE) were evaluated using an experimental carbon tetrachloride (CCl)-induced liver disease model. Potential targets of GPE were predicted using the "Drug-Disease" bioinformatic analysis. Furthermore, comprehensive network pharmacology and transcriptomic approaches were employed to investigate the underlying mechanisms of GPE in the treatment of liver disease.

Results: The pathological examinations showed that GPE significantly alleviated hepatocyte necrosis and liver injury. GPE significantly downregulated Bax and cleaved-PARP expression and upregulated Bcl-2 expression during CCl-induced hepatocyte apoptosis. We compared the effects of four typical compounds in GPE -a ginsenoside (Rb3) shared by both GPE and ginseng and three unique gypenosides in GPE. Notably, Gypenoside A (GPA), a unique saponin in GPE, markedly reduced hepatocyte apoptosis. In contrast, ginsenoside Rb3 had a weaker effect. Network pharmacology and transcriptomic analyses suggested that this anti-apoptotic effect was achieved by upregulating the PI3K/Akt signaling pathway mediated by PDK1.

Conclusions: These results suggested that G. pentaphyllum had a promising hepatoprotective effect, with its mechanism primarily involving the upregulation of the PDK1/Bcl-2 signaling pathway by GPA, thereby preventing cell apoptosis.

References
1.
Meng F, Zhang Y, Li X, Wang J, Wang Z . Clinical significance of miR-138 in patients with malignant melanoma through targeting of PDK1 in the PI3K/AKT autophagy signaling pathway. Oncol Rep. 2017; 38(3):1655-1662. DOI: 10.3892/or.2017.5838. View

2.
Hernandez-Alvarez M, Sebastian D, Vives S, Ivanova S, Bartoccioni P, Kakimoto P . Deficient Endoplasmic Reticulum-Mitochondrial Phosphatidylserine Transfer Causes Liver Disease. Cell. 2019; 177(4):881-895.e17. DOI: 10.1016/j.cell.2019.04.010. View

3.
Marrero J, Kulik L, Sirlin C, Zhu A, Finn R, Abecassis M . Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018; 68(2):723-750. DOI: 10.1002/hep.29913. View

4.
Kim J, Han Y . Dammarane-type saponins from Gynostemma pentaphyllum. Phytochemistry. 2011; 72(11-12):1453-9. DOI: 10.1016/j.phytochem.2011.04.003. View

5.
Zhang D, Zhang Y, Sun B . The Molecular Mechanisms of Liver Fibrosis and Its Potential Therapy in Application. Int J Mol Sci. 2022; 23(20). PMC: 9604031. DOI: 10.3390/ijms232012572. View